Breakdown | |||||
TTM | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 |
---|---|---|---|---|---|
Income Statement | Total Revenue | ||||
25.33B | 24.99B | 27.11B | 23.62B | 22.44B | 23.92B | Gross Profit |
3.71B | 3.80B | 3.54B | 3.07B | 2.69B | 2.87B | EBIT |
961.41M | 1.16B | 893.75M | 784.50M | 467.60M | 542.43M | EBITDA |
2.15B | 2.50B | 3.46B | 1.92B | 1.88B | 1.49B | Net Income Common Stockholders |
704.49M | 796.77M | 1.49B | 523.15M | 542.24M | 244.18M |
Balance Sheet | Cash, Cash Equivalents and Short-Term Investments | ||||
5.61B | 5.61B | 5.03B | 4.11B | 5.01B | 5.36B | Total Assets |
38.14B | 38.14B | 37.84B | 36.88B | 33.78B | 32.32B | Total Debt |
9.48B | 9.48B | 10.34B | 10.85B | 9.45B | 9.30B | Net Debt |
4.89B | 3.87B | 5.31B | 6.74B | 4.44B | 3.95B | Total Liabilities |
14.59B | 14.59B | 15.92B | 16.80B | 14.49B | 14.68B | Stockholders Equity |
20.62B | 20.62B | 19.28B | 17.64B | 17.07B | 16.70B |
Cash Flow | Free Cash Flow | ||||
0.00 | 1.60B | 1.80B | -2.07B | -1.17B | 950.38M | Operating Cash Flow |
0.00 | 2.15B | 2.68B | 1.32B | 1.37B | 1.79B | Investing Cash Flow |
0.00 | -754.05M | -1.65B | -2.13B | -3.91B | -879.01M | Financing Cash Flow |
0.00 | -1.02B | -948.09M | 1.21B | 1.09B | 134.39M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
---|---|---|---|---|---|---|---|
81 Outperform | ¥8.58B | 11.49 | 2.50% | 2.20% | -6.32% | ||
79 Outperform | ¥11.75B | 12.80 | 2.37% | 14.84% | 7.57% | ||
76 Outperform | ¥13.13B | 14.31 | 1.87% | 3.54% | 6.14% | ||
76 Outperform | ¥5.04B | 5.57 | 2.36% | 0.09% | 100.67% | ||
75 Outperform | ¥52.82B | 18.85 | 1.92% | 11.47% | 21.72% | ||
71 Outperform | ¥25.52B | 15.92 | 2.68% | 5.01% | -5.51% | ||
65 Neutral | $4.44B | 12.22 | 5.28% | 248.14% | 4.08% | -12.12% |